DekaBank Deutsche Girozentrale’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio SGNT Stock Details SGNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-19,500	Closed	-$292K	–	1070
2016 Q2	$292K	Buy	19,500 +5,400	+38%	+$69.4K	﹤0.01%	790
2016 Q1	$173K	Sell	14,100 -2,500	-15%	-$35.1K	﹤0.01%	870
2015 Q4	$263K	Buy	16,600 +500	+3%	+$7.87K	﹤0.01%	819
2015 Q3	$247K	Buy	16,100 +600	+4%	+$13K	﹤0.01%	819
2015 Q2	$377K	Buy	15,500 +500	+3%	+$12K	﹤0.01%	761
2015 Q1	$349K	Sell	15,000 -2,100	-12%	-$55.6K	﹤0.01%	796
2014 Q4	$437K	Sell	17,100 -1,600	-9%	-$46.9K	0.01%	717
2014 Q3	$582K	Buy	18,700 +400	+2%	+$10.8K	0.01%	624
2014 Q2	$473K	Sell	18,300 -1,300	-7%	-$28.9K	0.01%	606
2014 Q1	$458K	Buy	+19,600	New	+$429K	0.01%	587

DekaBank Deutsche Girozentrale's SGNT Position: Q3 2016 in Review

DekaBank Deutsche Girozentrale sold out of SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) in Q3 2016, closing a stake of 19,500 shares — an estimated $292K sold.

DekaBank Deutsche Girozentrale first reported a position in SGNT in Q1 2014 and held it in 10 quarters. The position peaked at $582K in Q3 2014. 0 funds tracked by Wall St. Rank hold SGNT as of Q3 2016.

DekaBank Deutsche Girozentrale reported no remaining SAGENT PHARMACEUTICALS INC COM STK (DE) position as of Q3 2016 after selling out during the quarter.
DekaBank Deutsche Girozentrale sold 19,500 SAGENT PHARMACEUTICALS INC COM STK (DE) shares in Q3 2016, an estimated $292K.
DekaBank Deutsche Girozentrale first reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) in Q1 2014 and held it in 10 quarters.
DekaBank Deutsche Girozentrale's SAGENT PHARMACEUTICALS INC COM STK (DE) position peaked at $582K in Q3 2014.
0 funds tracked by Wall St. Rank held SAGENT PHARMACEUTICALS INC COM STK (DE) as of Q3 2016.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q3 2016, filed 8 Nov 2016.